Neuralstem, Inc. News Headlines

CUR 
$2.87
*  
0.08
2.87%
Get CUR Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading CUR now
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
4 Bold Biotech Calls For 2014
12/26/2013 9:00:00 AM - Seeking Alpha


Athersys (ATHX) in Focus: Stock Moves 6.8% Higher - Tale of the Tape
12/16/2013 9:32:01 AM - Zacks.com


Can The Uptrend Continue for Neuralstem, Inc. (CUR)? - Tale of the Tape
12/2/2013 10:07:08 AM - Zacks.com


Cash, Catalysts, And Charisma Should Drive Neuralstem Well Above $3
11/4/2013 10:42:00 AM - Seeking Alpha


Cash, Catalysts And Charisma Should Drive Neuralstem Well Above $3
11/4/2013 9:43:00 AM - Seeking Alpha


Neuralstem: Evidence Increasingly Suggests Its Neural Stem Cells Are Effective In ALS
9/19/2013 6:32:00 PM - Seeking Alpha


Why Neuralstem Represents An Enormous Opportunity For Investors
9/9/2013 9:59:00 AM - Seeking Alpha


NeoStem And Neuralstem: 2 Early Regenerative Medicine Winners
9/8/2013 2:40:00 PM - Seeking Alpha


Healthcare Sector Slightly Higher Near Bell; Neuralstem Gains After Pricing $4-Mln Private Offering
9/5/2013 2:41:00 PM - MT Newswires


Sector Update: Healthcare
9/5/2013 2:39:45 PM - MT Newswires


Biotech: A Scattershot Of Stem Cell Plays Following Yesterday's Bloodbath
8/27/2013 11:00:00 PM - Seeking Alpha


Neuralstem's Pipeline Addresses Enormous Unmet Medical Needs
8/12/2013 4:32:00 PM - Seeking Alpha


SmithOnStocks Opines: June 9, 2013
6/9/2013 10:25:00 PM - Seeking Alpha


SmithOnStocks Opines Week Of June 2, 2013
6/3/2013 7:00:00 AM - Seeking Alpha


SmithOnStocks Opines On Biotechnology Stocks, May 24, 2013
5/27/2013 10:09:00 AM - Seeking Alpha


Neuralstem Phase I Results Encourage Market, Stimulate Buying
5/22/2013 7:33:00 AM - Seeking Alpha


Neuralstem: Update On Phase I Trial Of Neural Stem Cells In ALS Is Encouraging
5/21/2013 7:18:13 AM - SeekingAlpha


A Focus On Stem-Cell Therapy And Regenerative Medicine For 2013
5/20/2013 11:38:00 AM - Seeking Alpha


SmithOnStocks Opines On Stocks: May 19th Edition
5/19/2013 8:32:00 PM - Seeking Alpha


Neuralstem: Update On ALS Trial Could Be A Catalyst For The Stock
5/16/2013 9:55:00 AM - Seeking Alpha


Neuralstem Rounding Second With Phase II ALS Trial
5/16/2013 7:56:00 AM - Seeking Alpha


SmithOnStocks Opines On Recent Biotech News
5/13/2013 5:38:00 AM - Seeking Alpha


Neuralstem: Anticipating More Efficacy Data From ALS Trial And Update On New Clinical Trials
5/7/2013 1:07:29 PM - SeekingAlpha


StemCells Inc: CEO Martin McGlynn Is Building A Blockbuster Company
5/2/2013 8:11:00 AM - Seeking Alpha


Stem Cells: Invest At Your Own Peril
5/1/2013 5:33:00 AM - Seeking Alpha